INTRODUCTION Biological Rhythms
Many behaviors (e.g. sleep-wake, feeding) as well as physiological (e.g. body temperature, blood pressure) and endocrine (e.g. plasma corticosteroid concentration) events display a 24 h rhythmicity in mammals. These 24 h rhythms are induced by a timing system that is composed of central and peripheral clocks (1) .The suprachiasmatic nucleus (SCN) of the hypothalamus is the central pacemaker or the master clock (2) . The SCN receives input from many other brain areas and also has efferents towards many areas, several of them to the hypothalamus (3) . Lesions of the SCN disturb circadian rhythmicity in a variety of behavioral, endocrine, and biochemical processes (4) . Aside from the circadian endogenous rhythms, there are endogenous rhythms with shorter periods, ranging from seconds to hours, called ultradian rhythms, as well as longer rhythms lasting from a week or a month to a year. There are unsolved questions as to the role of the SCN in relation to these other rhythms. SCN lesions suppress some but not all ultradian rhythms.
These lesions also modify the seasonal rhythm of reproduction of several mammals (5, 6) . SCN lesions in rats suppress the scale-invariant patterns of motor activity within a 4-24-hour time range, which suggests a general role of the SCN in rhythm generation, i.e. not only for circadian rhythms (7) . Although light is the most important zeitgeber that directly influences the output of multiple oscillator systems, SCN together with peripheral clocks, enables a time-related homeostasis in case the external time cues such as daylight are not available (5) .
Despite, there is a biological sustainability, psychiatric disorders and also psychotropic medications have important effects on synchronizations of biological clocks (8) (9) (10) (11) .
Biological Rhythms and Psychiatry
The major marked clinical feature in affective disorders is their periodic nature, in a large range from seasonal depression to rapid cycling of bipolar disorders (12) . "In winter depression," the most common form of seasonal affective disorder, patients experience major depressive episodes beginning with the onset of winter, followed by remission or even hypomania in the spring (13, 14) . Also, many patients with non-seasonal depression show a regular daily pattern of symptoms, usually symptoms are more severe in the mornings (15) . Suicide rates also show both diurnal and seasonal variations (16) .
Phase-advanced oscillations in plasma cortisol and norepinephrine compared to healthy subjects, and abnormal levels and patterns of melatonin secretion may reflect the fundamental signs of disturbed biological rhythms in depressed patients (17) (18) (19) . There is clinical and epidemiological evidence that sleep disturbances in depression constitute a risk factor for poor clinical outcomes. Specifically, complaints of insomnia precede the onset and recurrence of depression (20) . Some researchers found shortening in Rapid Eye Movement (REM) sleep latency in bipolar disorder not only in depressive episode but also in mania. Furthermore, there was great variability of sleep duration and increased nocturnal time awakening in remitted BPD outpatients (21) . Some studies conducted on drug free patients, found that decreased sleep efficiency, reduced total sleep time, and elevated sleep latency in schizophrenia (22) .
Chronopharmacology
Because it is not the main topic of this review, we only 
Chronobiotics
Chronobiotic is defined as a substance that "adjusts the timing of internal biological rhythms" or "a substance that may adjusts or prevent the timing of the central biological clock" (32) .
Psychotropic Drug Effects on Clock Genes
Clock genes have an important role on the regulation of circadian rhythms. These genes include Clock, Bmal1 (ARNTL), period genes (Per1, 2, 3), cryptochrome genes (Cry1, 2), casein kinase Ie (CSNK1e) and Rev-erb-a (Nr1d1) (33, 34) . The mRNA levels of numerous core clock genes change in depression including cryptochrome (CRY1, CRY2), period (PER1, PER2, PER3), BMAL1 (ARNTL), and CLOCK. A sleep deprivation study in BPD (Bipolar Disorder) depressed patients indicated a reduction in baseline CRY2 mRNA levels compared to controls (35, 36) . Following one night of sleep deprivation CRY2 mRNA levels increased 2-fold in controls but did not significantly change in depressed subjects (37) . Mice with a mutation in Clock (Clock D19) have manic-like behaviours which can be suppressed by lithium (38, 39) . A follow-up study in mice with a knockdown of Clock in the ventral tegmental area documented changes in activity which the investigators interpreted as a mixed state of manic and depressive behaviors. In these animals, locomotor activities were increased in response to novel stimuli yet overall activity in the home cage was decreased (40) . It is challenging to report that the Clock mutation phenotype can be suppressed by melatonin (or the melatonin agonist, ramelteon) to stabilize circadian rhythms (41) .
Effects of Antidepressants on Sleep
Before the assessment of the each antidepressant 
Bupropion
It has effective via NA and DA reuptake inhibition. It decreases REM latency and increases total percentage of REM, and improve sleep efficiency (58).
Venlafaxine and Duloxetine
At lower doses, Venlafaxine has significantly sleep disturbing effects like SSRIs, and it caused by possibly effects of serotonin reuptake inhibition (47, 59, 60) . Although 60 mg/day Duloxetine reduced to sleep continuity, 80 mg/ day Duloxetine had significant improvement in sleep, and it has been emphasized that dose dependent change in SNRI effects on sleep continuity (61) .
Mirtazapine
This special molecule has been opposite effects with Similar to the antihistaminic agents, Mirtazapine's sleep promoting effect is rapid, and it can cause daytime sedation. Although histaminergic blockage helps to rapid sleep onset, it is assumed that the effects on continuity is due to its 5HT2 and 5HT3 blocking effects (62, 63) .
Trazodone
There is no REM suppressive effect due to its weak 5-HT reuptake inhibition. Its hypnotic dose range is 50-200 mg, although antidepressant dosage should be three times more (64) .
Melatonin and Melatonin Agonists
Melatonin is a hormone synthesized by the pineal gland. Its secretion occurs only at night in both diurnal and nocturnal mammals (65) . Circadian rhythm regulation via SCN, depends on the regularly secretion of pineal melatonin and existence of healthy melatonin receptors in SCN as well (66) . In healthy subjects, DimLight Melatonin Onset (DLMO) occurs 1-2 h before sleep onset. In depressed patients, DLMO is usually delayed and melatonin levels are decreased (67, 68) . In depressive patients there are some single nucleotide polymorphisms (SNPs) in the melatonin pathway such as arylalkylamine N-acetyltransferase (AANAT) (69) and a rate-limiting melatonin enzyme acetylserotonin methyltransferase (ASMT) (70) . Melatonin is a prototype of chronobiotics and the chemical code of darkness (43) . The effects of melatonin on SCN activity are mediated by at least two receptors; MT2 receptors that sensitive at dusk and dawn and causes phase shifts, and MT1 receptors that decreases the neuronal firing rate at early evening (71, 72) .
Ramelteon
It is a selective MT1 and MT2 receptor agonist. It has both sleep-promoting and chronobiotic effects (73) .
Agomelatine
Agomelatine has no effects on pre or post synaptic 5 HT1A receptors and its mechanism of action is different from TCA and SSRIs. Agomelatine is significantly effective on a several behavioral models of antidepressant properties, such as forced-swim test (74) , the learned helplessness paradigm in rats (75), the olfactory bulbectomized rat model (76) , and the chronic mild stress test (77) . In the chronic mild stress model, agomelatine remains effective independently of the administration time, shows that its antidepressant activity is not only due to its action at melatonergic receptors, but also related to the antagonistic activity at 5-HT2C receptors.
Mood Stabilizers Carbamazepine
It was shown to increase SWS and decrease REM sleep.
This study was conducted with 7 temporal lobe epilepsy patients and 9 healthy controls. In both groups, fragmentation of REM and increase in sleep shifts were observed (78) . Another article reported increased SWS and sleep efficacy, decreased awakenings, and decreased sleep latency (79) . However, there are some studies reporting no difference in sleep architecture with carbamazepine (80, 81) .
Valproic Acid (VA)
In a study, it was found that VA increases Stage 1, decreases stage 2 sleep, causes difficulty in initiating sleep, and reduces REM sleep (82) , while the another study reported that VA has a little or no effect on sleep architecture (83) .
Lithium
Lithium lengthens circadian rhythm period in plants, rodents, and mammalians including humans (84) .
Although the knowledge about the Lithium's efficacy in (42, 43) N/A ↑ ↓ ↑ ↑ ↓ Carbamazepine (42,43,78, antiserum to prolactin decreases REM sleep in rats (96, 97) . In patients with hyperprolactinoma, SWS is selectively increased compared to the controls (98).
Repetitive ghrelin administration increases SWS, and also GH, ACTH, and cortisol levels increase after ghrelin, in young men (99) . Intrahypothalamic ghrelin increases feeding and wakefulness in rats (100) . In a patient with night-eating syndrome, nocturnal ghrelin levels appeared to be elevated (101) . Psychotropic medication effects on sleep are summarized at table 1. 
CONCLUSIONS

Conflict of Interest
None of the authors had any conflict of interest to declare.
